{
    "2020-02-28": [
        [
            {
                "time": "2023-10-10",
                "original_text": "The Zacks Analyst Blog Highlights: Abbott Laboratories, Myriad Genetics, LabCorp, QIAGEN and Thermo Fisher",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Abbott Laboratories",
                        "Myriad Genetics",
                        "LabCorp",
                        "QIAGEN",
                        "Thermo Fisher"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "The 50 largest public companies in Mass. lost $95B in value this week",
                "features": {
                    "keywords": [
                        "50 largest public companies",
                        "Mass.",
                        "lost",
                        "$95B",
                        "value",
                        "this week"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}